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1 Introduction
Asthma is a chronic inflammatory airway disease that has emerged as a major health concern among in-
dustrialized nations (Zhu & Gilmour, 2009). Asthma is a heterogeneous disorder that is characterized by
variable airway obstruction, airway inflammation and hyperresponsiveness (Lemanske, Jr. & Busse, 2010).
For many asthmatics, the disease has its roots during infancy and early childhood. However, in adult asthma,
occupational exposures are estimated to be responsible for 10% to 25% of the asthma prevalence (Mapp
et al., 2005). Today, occupational asthma (OA) has become the most common work-related lung disease
and can be defined as a disease characterized by variable airflow limitation and/or airway hyperresponsive-
ness due to causes and conditions attributable to a particular occupational environment and not to stimuli
encountered outside the workplace (Bernstein et al., 2006). Depending on their molecular weight, agents
causing allergic or immunologically mediated OA can be divided into two categories: a/ biological agents
of high molecular weight (HMW) (> 5kDa), such as proteins, glycoproteins and polysaccharides b/ chemi-
cals of low molecular weight (LMW) (< 5kDa), such as synthetic chemicals, natural compounds, drugs and
metals. HMW and certain LMW compounds generally induce OA via IgE-dependent mechanisms, com-
parable with atopic asthma induced by pollen or house dust mite allergens, whereas many (though not all)
LMW compounds (isocyanates, western red cedar) appear to induce OA via pathways that do not involve
IgE-dependent mechanisms (Mapp et al., 2005).
Although exposed to similar allergic stimuli, not all humans develop allergic or occupational asthma.
The etiology of asthma is complex and is associated with a combination of immune, genetic, environmental
and socio-economic factors (Tumes et al., 2007; Zhu & Gilmour, 2009).
The mouse genome has been extensively characterized and exhibits a high degree of homology with
its human counterpart. Especially, a high level of resemblance at the immunological level has been found,
suggesting that mouse models can yield a relevant insight into human pathology (Willis-Owen & Valdar,
2009). Maximum genetic uniformity can be achieved when using inbred strains. Environmental factors
such as exposure to light, diet, air quality and climate can influence the phenotypic outcome of asthma. The
advantage of using an animal model is that these confounding factors can be largely controlled in laboratory
animal housing situations (Tumes et al., 2007; Wills-Karp & Ewart, 1997). Using different inbred strains of
mice gives the opportunity to estimate the influence of the genetic background on the phenotypical outcome
of chemical-induced asthma.
Starting from an established mouse model of chemical-induced asthma developed by Vanoirbeek et
al. in BALB/c mice, 6 other inbred mouse strains were tested on their sensitizing capacity to toluene-2,4-
diisocyanate (TDI) (De Vooght et al., 2009; Vanoirbeek et al., 2004; Vanoirbeek et al., 2006; Vanoirbeek et
al., 2008; Vanoirbeek et al., 2009a). By testing different mouse strains we have the opportunity to evaluate
the intra- (experimental) and the inter-strain variability, giving us the possibility to select the inbred mouse
strain which represents best the phenotype of human OA.
2 Materials and Methods
2.1 Diisocyanates
Diisocyanates are a leading cause of OA and are therefore frequently used in animal models to unravel the
mechanisms behind chemical-induced non-IgE-mediated OA. Diisocyanates are LMW agents that contain
two highly reactive isocyanate groups (-N=C=O) which can bind to endogenous proteins. These chemi-
cals are widely used in industry for manufacturing polyurethane foams, paints and lacquers (Piirila et al.,
2001). The three predominant diisocyanates in use today are toluene diisocyanate (TDI), diphenylmethane
diisocyanate (MDI) and hexamethylene diisocyanate (HDI) (Liu & Wisnewski, 2003).
For dermal applications, the vehicle (AOO) for TDI consisted of 2 volumes of acetone (A) and 3
volumes of olive oil (OO). For the oropharygeal aspiration (challenge) the vehicle (AOO) consisted of a
mixture of 1 volume of acetone and 4 volumes of olive oil. The vehicle matrix, in which a chemical allergen
is dissolved, can have profound effects on the response elicited (Basketter et al., 2001). AOO is one of the
standard vehicles for the local lymph node assay (OECD 2002, guideline 429) and it has been proven to
be an ideal vehicle for non-aqueous compounds like TDI. We optimized the proportions of A and OO for
dermal sensitization and challenge to avoid irritation, inflammation or airway response, in the control group
(De Vooght et al., 2009; Vanoirbeek et al., 2004).
2.2 Inbred Mouse Strains
In allergy and asthma research, several protocols for the induction phase and elicitation phase are used as
well as different strains of mice. Mostly, these are inbred mouse strains, implying that approximately 99%
of all loci are homozygote. So, these mice are genetically identical. Although they are genetically identical
within a mouse strain, this is not the case between the mouse strains. The inbred strains of mice have been
shown to differ in their ability to mount an allergen-induced asthmatic response. To compare different inbred
mouse strains in a mouse model of diisocyanate-induced OA, male BALB/c OlaHsd, A/J OlaHsd, C57Bl/6J
OlaHsd, AKR OlaHsd, DBA/2 OlaHsd, CBA/J CrHsd and BP/2IcRj-Biozzi mice (6 weeks old) were used.
These mouse strains can be categorized in Th2-biased (BALB/c, BP2 and A/J) or Th1-biased (C57Bl/6,
AKR, DBA/2 and CBA) mouse strains and we could hypothesize, based on the known mechanisms of
asthma, that the former mouse strains would be more responsive than the latter.
2.3 Mouse Model of TDI-Induced OA
Vanoirbeek et al. and De Vooght et al. developed, optimized and validated a mouse model of chemical-
induced asthma (De Vooght et al., 2009; De Vooght et al., 2010; Tarkowski et al., 2007; Vanoirbeek et
al., 2004; Vanoirbeek et al., 2006; Vanoirbeek et al., 2008; Vanoirbeek et al., 2009b; Vanoirbeek et al.,
2009a). The mouse model consists of dermal sensitizations followed by a single airway challenge. The
choice of skin exposure as a sensitization route originates from the fact that several industrial applications
of LMW agents provide a high opportunity for skin exposure. Furthermore, it is known that the prevalence
of chemical-induced asthma does not tend to decrease despite reductions in airway exposure.
The treatment protocol consist of two dermal applications of TDI in AOO (2:3) on days 1 and 8 on
the dorsum of both ears (0.3% TDI), followed by a single airway challenge (day 15) via oropharyngeal
aspiration (0.01% TDI) with a lower concentration of TDI in AOO (1:4) (De Vooght et al., 2009).
2.4 Functional, Inflammatory and Immunologic Parameters
2.4.1 Forced Oscillation Technique versus Whole Body Plethysmograph
Pulmonary function analysis is an important tool in the evaluation of mouse respiratory disease models, but
the development of these tests has been a great challenge in small animals. At present there are different non-
invasive and invasive measurements available (Vanoirbeek et al., 2010). Until recently, unrestrained whole
body plethysmography (WBP) was widely used to assess bronchial hyperresponsiveness in conscious, free
to move and spontaneously breathing mice. The principle behind the WBP is the measurement of pressure
differences, caused by respiration, between a reference chamber and the main chamber containing the an-
imal. Bronchocontriction can cause marked changes in the breathing pattern and this will be reflected in
the dimensionless parameter enhanced pause (Penh) (Hamelmann et al., 1997). Although a main advantage
is the noninvasive character of the technique, over the years this method has been heavily criticized. This
criticism is based on the fact that the pressure differences measured are not solely due to changes in breath-
ing of the animals, but they are largely caused by gas compression and the humidification and heating of
air as it moves between the box and the lungs (gas conditioning). Consequently, changes in Penh are only
useful as a general indicator that some reaction has taken place in an animal, but may not be correlated with
mechanical properties of the lung (Lundblad et al., 2002). Measuring respiratory mechanics can only be
achieved with more invasive measurements, for example the forced oscillation technique, in anesthetized
and tracheostomized mice. Here the animal’s breathing pattern is entirely under the control of the experi-
menter, and the upper airways are bypassed so that their mechanical properties do not interfere with those
of interest (i.e. the lung) (Bates et al., 2009). The forced oscillation measurements can be performed with
the FlexiVent (SCIREQ) system. In our research group, mice are anesthetized with an intraperitoneal injec-
tion of pentobarbital (70 mg/kg). This anesthetic will, besides sedation, also suppress spontaneous breading
needed to perform stable measurements. Subsequently the animals are tracheostomized and connected to a
computer-controlled small animal ventilator. The mice are quasi-sinusoidal ventilated with a tidal volume
of 10 ml/kg at a frequency of 150 breaths/min and a positive end-expiratory pressure of 2 cmH2O to achieve
a mean volume close to that during spontaneous breathing. A broad range of parameters can be measured at
baseline or after a methacholine provocation. A methacholine provocation is performed to measure airway
hyperreactivity (AHR, 24 hours after the specific challenge) and is achieved by administering increasing
concentrations of methacholine (0-10 mg/ml) via an in-line nebulizer which is directly connected to the
ventilator. This in-line nebulizer makes it also possible to expose mice to different aerosolized compounds
before or during measuring lung mechanics (De Vooght et al., 2009; Vanoirbeek et al., 2010).
2.4.2 Pulmonary inflammation (bronchoalveolar lavage)
Airway inflammation is besides a reversible airway obstruction and non-specific AHR a typical characteris-
tic of (allergic) asthma. In comparison with asthma induced by HMW agents, were eosinophils and lympho-
cytes are the characteristic cell types present in the bronchoalveolar lavage (BAL) fluid, asthma induced by
LMW agents has been associated with an influx of mainly neutrophils and to a lesser extent eosinophils (De
Vooght et al., 2009; Lee et al., 2001; Matheson et al., 2001; Scheerens et al., 1996; Tarkowski et al., 2007;
Vanoirbeek et al., 2004). The type of inflammation is highly dependent on the used treatment protocol.
The duration of exposure (acute or chronic), the route of exposure (intranasal, oropharyngeal, inhalation,
intratracheal) as well as the option of conjugating the chemical with serum albumine can influence the in-
flammatory outcome (Ban et al., 2006; De Vooght et al., 2009; Herrick et al., 2002; Matheson et al., 2005b;
Vanoirbeek et al., 2004; Wisnewski et al., 2011).
The easiest way to assess airway inflammation in mice is to perform a BAL of one or both lungs. This
BAL fluid can then be used to verify differences in total or differential cell count as well as differences in
cytokine concentrations. Another way is to collect lung tissue samples and measure cytokine concentrations
in tissue homogenates or perform lung histology on cryosections or paraffin imbedded slides, depending on
the research purpose.
2.4.3 Immunologic Parameters
One of the first steps in the immune response is the recognition of the antigen by antigen presenting cells
present in the skin and mucosal sites. When properly stimulated, antigen presenting cells will migrate to the
draining lymph nodes where they present antigen and stimulatory signals to T-lymphocytes leading to their
activation (Afshar et al., 2008). These lymph nodes are defined as secondary lymphoid organs and provide a
supporting framework in which antigens and rare antigen-specific T- and B-lymphocytes can be efficiently
brought together to initiate the adaptive response (Phan et al., 2009). Activation of the T-lymphocytes leads
to the production of IL-4 and IL-13 that regulates the isotype switch of B-lymphoyctes and their production
of immunoglobulins, such as IgE and IgG (Maddox & Schwartz, 2002). Together with IL-9, these cytokines
are also important in mast cell development, mucus overproduction and the induction of AHR. Re-exposure
to the allergen leads to cross-linking of the allergen on mast cell bound IgE resulting in the release of
preformed and newly synthesized mediators and the transcription of cytokines. This will lead to the early-
phase of an asthmatic reaction resulting in mucus production, bronchoconstriction, vascular leak, and the
initial recruitment of T-lymphocytes in the airways. The early phase of an asthmatic reaction is initiated
within minutes, and is subsequently followed several hours later by a late phase reaction distinguished by
an influx of neutrophils and eosinophils into the airways. This influx of inflammatory cells is the result of
the secretion of IL-3, IL-5 and granulocyte colony stimulating factor (GM-CSF) by mast cells and T-helper
(Th) 2 lymphocytes (Afshar et al., 2008; Bloemen et al., 2007).
Although allergen-induced cross-linking of IgE on the surface of mast cells is a cardinal feature
to “trigger” allergic asthma, it has been reported that the majority of individuals with isocyanate-induced
asthma do not have allergen-specific IgE (Wisnewski & Jones, 2010). It has been suggested that sensitiza-
tion to isocyanates can be achieved via other immunological mechanisms, such as direct T cell activation,
or on the other hand, that IgE goes undetected for largely technical and methodological reasons (Lutz &
Palczynski, 2003; Maestrelli et al., 2009). Until now, the role of IgE in the pathophysiology of OA is still
uncertain at best.
The assessment of the different subpopulations of lymphocytes in the draining lymph nodes of the
ear and their cytokine production, in our mouse model of chemical-induced asthma, gives the necessary
information on sensitization status as well as the profile of the activated lymphocytes.
3 Results and Discussion
Seven mouse strains were tested in an established mouse model of chemical-induced asthma (De Vooght
et al., 2009; Vanoirbeek et al., 2004; Vanoirbeek et al., 2006; Vanoirbeek et al., 2008; Vanoirbeek et al.,
2009a). The main findings of this study were that, in general, Th2-biased mice reproduce better than Th1-
biased mice, the features that characterize human occupational asthma. BALB/c mice showed the most
pronounced differences in AHR, airway inflammation and immunologic parameters, compared to the two
other Th2-biased mouse strains tested (BP2 and A/J). Th1-biased mice, however, were not completely non-
responsive.
Mice are the most commonly used species to develop experimental models of human diseases. Mice
are easy to breed, economical to house and relatively easy to work with. Furthermore, the mouse genome
has been extensively studied and it exhibits a high degree of homology with the human genome. Further
advantages are the wide variety of available immunological and molecular reagents as well as transgenic
animals (Dearman & Kimber, 2009; Willis-Owen & Valdar, 2009).
Besides the many advantages of animal models, there is still a lot of controversy concerning the use
of animals to study human disease. Thus, mice do not spontaneously exhibit symptoms consistent with
asthma. Different treatment protocols have been developed to mimic the phenotypes of human asthma, but
no mouse model is currently able to mimic the full range of clinical manifestations. Furthermore, important
differences exist in airway development and morphology between humans and mice. Mouse airways have
fewer airway generations and do not contain smooth muscle bundles. Nevertheless, although mice cannot
be considered as perfect surrogates for humans, they can be used to test hypotheses in a relatively simple
controlled system (Dallas M.Hyde et al., 2009; Wenzel & Holgate, 2006; Willis-Owen & Valdar, 2009).
In view of the above considerations, it is important to standardize techniques and protocols used, to
be able to compare the results of different research groups. So far, the influence of the genetic background
of mice on ventilatory and immunological parameters has not been studied much. Our study is one of the
first to have compared multiple endpoints of immune-mediated asthma in a large number of inbred mouse
strains. It is surprising how little is known about genetic differences between the commercially available
inbred mouse strains, which makes it hard to link phenotypic differences in parameters to genetic variability.
So far, our ventilatory, inflammatory and immunologic results can only be linked to a predominant Th1- or
Th2-bias.
3.1 Ventilatory Results
Clear differences were found in AHR to methacholine in the different mouse strains. Th2-biased mouse
strains showed increases in AHR compared to Th1-biased mice (Fig 1), as already shown by different other
research groups in other asthma models (Al Qadi-Nassar et al., 2007; Brewer et al., 1999a; Fukunaga et al.,
2007; Van Hove et al., 2009; Zhu & Gilmour, 2009). However, one exception is the AKR strain (Fig 1G
and 1H), which although being Th1-biased, responded significantly in terms of increase in AHR (Brewer et
al., 1999b). Furthermore, we found differences in baseline reactivity to methacholine between the different
Th2-biased mice. BP2 (Fig 1B and 1H) and A/J (Fig 1C and 1H) mice were found to be more sensitive to
methacholine provocation than BALB/c mice (Fig 1A and 1H) and this both for the TDI-treated animals
and the control mice. Among the three Th2-biased strains, the BALB/c mice presented the best separation
between TDI-sensitized plus TDI-challenged animals and the controls.
Differences in baseline AHR can be an intrinsic characteristic of the mouse strain. Differences in
alveolar size, lung volume, elastic properties and differences in controlling smooth muscle cells by the
autonomic nerve system have been described (Hadeiba et al., 2000; Soutiere et al., 2004; Tankersley et al.,
1999).
When we analyse our results of the AHRmore in detail, we can conclude that individual adjustments
for methacholine concentrations per mouse strain are preferable. A/J mice reach a plateau at 10 mg/ml
methacholine (Fig 1C), while C57Bl/6 mice are still at a submaximum at that concentration (Fig 1D). We
chose to perform the methacholine provocation with the same methacholine concentrations for each mouse
strain to make comparisons easier.
3.2 Inflammatory Results
In our model, airway inflammation in TDI-induced asthma is characterized by an influx of mainly neu-
trophils and also some eosinophils (De Vooght et al., 2009; Tarkowski et al., 2007; Vanoirbeek et al., 2008).
This study showed that BALB/c mice have the most pronounced airway inflammation of all 7 mouse strains
(Fig 2). However, our observations support that there is no consistent relationship between AHR and the
influx of neutrophils and eosinophils in the lungs, as already shown by Whitehead et al. (Whitehead et al.,
2003).
When using ovalbumin models, C57Bl/6 are often used and they respond with a robust airway
eosinophilic response (Herrick et al., 2003; Van Hove et al., 2009). It is conceivable, as suggested by
Herrick et al., that the ability to generate airway inflammation after chemical exposure is under different
and perhaps tighter genetic control than the ability to mount these responses after exposure to other antigens
(Herrick et al., 2003).
3.3 Immunologic Results
Significant increases in the total amount of Th-, T-regulatory-, T-cytotoxic- and B-lymphocytes were found
in all Th2-biased mouse strains and for some lymphocyte subpopulations also for the Th1-biased CBA and
AKR mice (Fig 3).
Vogelsang et al. already showed that there are different amounts of conventional and plasmacytoid
dendritic cells and Treg-lymphocytes in blood and spleen of BALB/c vs. C57Bl/10J mice (Vogelsang et al.,
2009). This confirms that the genetic background of the mouse strain plays a role in the development of
different immunologically linked cell subtypes and probably also in their cytokine production.
Increases in IL-4 were associated with increases in the total amount of B-lymphocytes and with
proportional increases in total serum IgE (Fig 4). However, BALB/c mice turned out to be limited producers
of total serum IgE compared to the other mouse strains tested. This raises again the question of the relevance
of IgE in chemical-induced asthma. For many low molecular weight compounds, specific IgE antibodies
have only been found in a small subset of patients (Chan-Yeung & Malo, 1995). The presence of total IgE
in serum serves as a marker of prior sensitization in mice, but has limited functional consequences. This
confirms the hypothesis of a non-IgEmediated cellularmechanism involved in the development of chemical-
induced asthma. In our data the amount of IL-4 does not always correlate with the level of IgE present in the
serum. IL-4 plays an important role in the production of IgE, but mediates also other pathways such as the
differentiation of Th-lymphocytes, the ability to induce the expression of vascular cell adhesion molecule
1 (VCAM-1) and the production of mucus in the asthmatic airway (Commins et al., 2010). Furthermore,
increases in the concentrations of IL-10, IL-13 and IFN-(g) (Fig 5) were mainly observed in the Th2-biased
mouse strains. The primary source of IL-10 are inducible Treg-lymphocytes, but IL-10 can also be produced
by B-lymphocytes and monocytes. IL-13 shares much of IL-4’s biologic activities. In murine studies IL-13
has an important role in causing mucus hypersecretion and AHR. IFN-(g) is the most important cytokine
responsible for cell-mediated immunity. It is produced by Th1-lymphocytes but is also derived from Tc-
!Figure 1: Airway hyperresponsiveness (AHR). The airway resistance (R), after increasing con-
centrations of methacholine (0-10 mg/ml), was measured 24 hours after the challenge. Figures
A) to G) reflect the airway hyperresponsiveness to increasing concentrations of methacholine
per mouse strain. Figure H) represents the area under the curve (AUC) of R per experimen-
tal condition and per mouse strain. Experimental groups are 0/0, 0/1 and 1/1. The first num-
ber identifies the agent used for the dermal applications (sensitizations) and the second number
identifies the agent used for the oropharyngeal aspiration (challenge). A treatment with toluene-
2,4-diisocyanate (TDI) is shown as 1 and a treatment with the vehicle (a mixture of acetone and
olive oil), is shown as 0. Data are presented as mean ± S.D. (A-G) and mean with individual
values (H), n = 5-11 per group. According to the D’Agostino & Pearson omnibus normality
test, the AUC data of the AHR are not normally distributed and therefore were analyzed with a
non-parametric Kruskal-Wallis test followed by a Dunn’s multiple comparison test (Graphpad
Prism 4.01). * p < 0.05, ** p < 0.01 and ∗∗∗p < 0.001 compared with the 0/0 group, #p < 0.05
and ###p < 0.001 compared with the 0/1 group.
!Figure 2: Differential cell count in BAL in different mouse strains. The lungs were lavaged with
3 times 1 ml saline and the number of macrophages, neutrophils and eosinophils was counted in
the BAL fluid. Figure A) represents the differential cell count in the Th2-biased mouse strains
and figure B) the differential cell count in the Th1-biasedmouse strains. Experimental groups are
identical to figure 1. Data are presented as means ± S.D., n = 6−14 per group. The differential
cell counts were not normally distributed and therefore were analyzed with a non-parametric
Kruskal-Wallis test followed by a Dunn’s multiple comparison test. ∗p < 0.05 and ∗∗ p < 0.01
compared to the 0/0 group, # p < 0.05 and ## p < 0.01 compared to the 0/1 group.
!Figure 3: Lymphocyte subpopulations in the auricular lymph nodes of different mouse strains.
Auricular lymph nodes were collected and FACS analyses were performed. A) CD3+CD4+ (Th-
lymphocytes), B) CD19+ (B-lymphocytes), CD3+CD4+CD25+ (activated/Treg-lymphocytes,
data not shown) and CD3+CD8+ (Tc-lymphocytes, data not shown) lymphocytes were charac-
terized. Experimental groups are the same as in figure 1. Data are presented as means ± S.D.,
n = 4−9, p < 0.05, ∗p < 0.01 and ∗∗ p < 0.001 compared to the 0/0 group, #p < 0.05, ##p < 0.01
and ###p < 0.001 compared to the 0/1 group.
!Figure 4: Total serum IgE in different mouse strains. Total serum IgE was measured 24 hours
after the challenge. Experimental groups are the same as in figure 1. Data are presented as means
± SD, n = 6− 14. IgE was analyzed with a one-way ANOVA test followed by a Bonferroni’s
multiple comparison test. ∗∗ p < 0.01 and ∗∗∗p < 0.001 compared to the 0/0 group, ##p < 0.01
and ###p < 0.001 compared to the 0/1 group.
lymphocytes and natural killer cells (Commins et al., 2010).
In an attempt to create a comprehensible overview of all the results combined, we made a radar
graph for each mouse strain (Fig 5). In the radar graphs the complete control group (0/0) (blue field) is
plotted against the complete TDI-treated group (1/1) (red field). The radar graphs visualize pronounced
differences between Th2- and Th1-biased mouse strains. While BALB/c, BP2 and A/J mice gave high
values in respiratory, inflammatory and immunological parameters characteristic for occupational asthma,
C57Bl/6 and CBAmice showed hardly any responses in our mouse model. In the context of “a mouse model
of chemical-induced asthma” both the limited response of the 0/0 group in the BALB/c mice, along with a
pronounced response in the 1/1 group, makes the BALB/c mouse strain the most favorable to use, at least
in the short term. When we approach the results from a different angle, we can also suggest that C57Bl/6
mice could be a good mouse strain to investigate why most people do not develop allergy and asthma, while
some do. The radar graphs show also that TDI sensitization yields a mixed Th1-Th2 profile, as previously
shown by us and other research groups, especially in the Th2-biased mouse strains (De Vooght et al., 2009;
Matheson et al., 2005b; Matheson et al., 2005a; Tarkowski et al., 2007; Vanoirbeek et al., 2008).
Therefore, in the context of chemical-induced asthma, it is not correct to state that a certain mouse
strain is more Th2-biased than Th1-biased.
3.4 Susceptibility Genes
In this experimental setup we did not go in detail into the genetic differences between the different mouse
strains. One of the reasons is the lack of proper information about the genetic composition of the different
strains. Because genetics probably play an important role in the outcome of an experiment, a short summary
is given about what is known in literature concerning susceptibility genes and quantitative trait loci (QTL)
in humans and inbred mice (De Vooght et al., 2010).
Although exposed to similar allergic stimuli, not all humans develop allergic or occupational asthma.
	  Figure 5: Radar graphs of the different mouse strains. The radar graphs give a visual overview
of all results combined for the complete control group (0/0) (blue field) versus the complete
TDI-treated group (1/1) (red field). Experimental groups are the same as in figure 1. The lower
limit of each axis is always 0. The upper limit of each axis is the maximum average for a specific
parameter measured in one strain and is presented as 100%.
The etiology of asthma is complex and is associated with a combination of genetic, immune, environmental
and socio-economic factors (Tumes et al., 2007; Zhu & Gilmour, 2009). Involvement of genetic back-
ground on chemical-induced asthma has already been shown previously in humans. Associations have
been found between diisocyanate-induced OA and glutathione-S-transferase (GST) and N-acetyltransferase
(NAT) polymorphisms as well as with human leukocyte antigen (HLA) alleles (Jones et al., 2006; Liu &
Wisnewski, 2003; Mapp et al., 2000; Wikman et al., 2002).
The presence of inflammation in the airways is an important biochemical feature of asthma. En-
zymes of the GST supergene family are critical in the protection of cells from reactive oxygen species
(ROS), key components in inflammation. Wide genetically based individual variations have been observed
in the GST enzyme activities, making them candidates as modifiers of susceptibility to diisocyanate-induced
asthma. Inability to detoxify ROS could therefore lead to inflammatory processes, activate bronchoconstric-
tor mechanisms and cause asthmatic symptoms (Piirila et al., 2001). In humans, the GSTM1 null genotype
was associated with a two-fold risk of diisocyanate-induced asthma and absence of diisocyanate-specific
IgE, the GSTM3 AA genotype with a late reaction in specific challenge testing, and the GSTP1 Val/Val
genotype with high total IgE levels. Furthermore, GSTP1 Val/Val genotype was associated with a nine-fold
lower risk of asthma than did GSTP1 Ile/Ile (Mapp et al., 2002).
Humans also exhibit large interindividual variation in NAT enzyme activities due to polymorphisms
in NAT1 and NAT2 genes. Diisocyanates may circulate in the body as glutathione conjugates. On the
other hand, after inhalation, diisocyanates come into an aqueous environment where they may hydrolyse
into diamines, which may subsequently undergo N-acetylation by NAT1 and NAT2. Subjects with slow N-
acetylation capacity may be at increased risk because hapten formation would be more favoured. Wikman
et al. found that the slow acetylator NAT1 genotypes posed a 2.5-fold risk of diisocyanate asthma. The
effect of the NAT1 genotype was especially marked for workers exposed to TDI, among whom the NAT1
genotypes posed a 7.8-fold risk of asthma (Wikman et al., 2002).
Besides the metabolizing enzymes GST and NAT, associations have been found with HLA class II
proteins encoded on chromosome 6. These are important factors for the specificity of the response to occu-
pational agents. Mapp et al. showed a positive association of HLA class II DQA1*0104 and DQB1*0503
with the disease, while DQA1*0101 and DQB1*0501 were significantly more prevalent is asymptomatic
exposed subjects (Mapp et al., 2000; Mapp et al., 2005).
Identification of genetic susceptibility loci has been difficult. The genetic mapping of asthma sus-
ceptibility in humans has been hampered by factors including variability in clinical phenotype, uncontrolled
environmental influences and genetic heterogeneity. Inbred murine models of asthma provide an attractive
option to investigate these complexities and genetic analyses of common disease phenotypes in this model
system may prove to be more fruitful. Inbred mice show strain-specific variation with respect to various
traits (e.g. a phenotypic characteristic) related to asthma (Ackerman et al., 2005). With QTL analysis, dif-
ferent regions of chromosomes that are associated with a particular trait can be found and this can lead to
identifying candidate genes. By characterizing strain distribution patterns for asthma related phenotypes,
Ewart et al. found in an OVA model that expression of AHR differed between strains and was sometimes
discordant with inflammation or serum IgE. This can be compared with the discrepancies we found in our
results, suggesting different genetic mechanisms underlying these traits (Ewart et al., 2000).
Although this is only a small selection of susceptibility genes and loci, it reflects well the complex-
ity of allergic and occupational asthma. The few animal studies depicted here can partially explain the
differences we found in our results concerning the different mouse strains.
4 Conclusion
In conclusion, this study, based on a comparison of seven different inbred mouse strains in a model of
chemical-induced asthma, demonstrates that the genetic background of the different mouse strains has a
large impact on the phenotypical outcome of TDI-induced asthma. Caution has to be taken when compar-
ing results from different mouse strains. Furthermore, in this model, BALB/c mice represented best the
characteristics of chemical-induced asthma.
Note
This book chapter was largly based on: De Vooght V, Vanoirbeek JA, Luyts K, Haenen S, Nemery B and
Hoet PH: Choice of mouse strain influences the outcome in a mouse model of chemical-induced asthma.
PLoS ONE 2010, 5(9):e12581.
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